Mesh-like scaffold is disordered in Alzheimer's-affected cells
Brain cell death in Alzheimer's disease is linked to disruption of a skeleton that surrounds the nucleus of the cells, a researcher in the School of Medicine at The University of Texas Health Science Center at San Antonio said.
The finding is expected to open new avenues of study of how to prevent the earliest biological events that result in Alzheimer's.
The nucleus is the control center of cells. A mesh-like scaffold called the lamin nucleoskeleton surrounds this control center but is disordered in Alzheimer's, said Bess Frost , Ph.D., assistant professor of cellular and structural biology at the UT Health Science Center at San Antonio. Dr. Frost was trained at Harvard Medical School and in November started her new laboratory at the UT Health Science Center's Barshop Institute for Longevity and Aging Studies.
Confirmed in human cells
Dr. Frost and two co-authors showed--for the first time--that lamin dysfunction can cause the death of brain cells, which are called neurons. The team made this finding in a fruit fly disease model initially and confirmed it in postmortem brain tissue of people who had Alzheimer's disease, whose families donated their brains to research.
"Human brain donation is a very critical part of this work," Dr. Frost said. "It was important to show that what we found in the fly is really relevant to human disease."
Dr. Frost and her colleagues used a technique called super-resolution microscopy to analyze the fruit fly and human specimens. They found peculiar features that looked like tunnels in the lamin of Alzheimer's-affected specimens.
Seems to be Alzheimer's-specific
The team also studied a fruit fly model of Huntington's disease and did not find any problems with the lamin. "So, at least compared to one other neurodegenerative disease, lamin dysfunction seems to be specific to Alzheimer's disease," Dr. Frost said.
Dr. Frost encourages people to consider brain donation, whether or not they have a neurodegenerative disease. Comparing healthy, normal brain tissue to diseased brain tissue is a very useful tool for neuroscientists, she said.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
